N. Ballatori, S. M. Krance, R. Marchan, and C. L. Hammond, Plasma membrane glutathione transporters and their roles in cell physiology and pathophysiology, Mol. Asp. Med, vol.30, pp.13-28, 2009.

S. P. Cole, Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future, Annu. Rev. pharmacology Toxicol, vol.54, pp.95-117, 2014.

M. Haber, Association of high-level MRP1 expression with poor clinical outcome in a large prospective study of primary neuroblastoma, J. Clin. Oncol, vol.24, pp.1546-1553, 2006.

I. Leier, The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates, J. Biol. Chem, vol.269, pp.27807-27810, 1994.

D. W. Loe, R. G. Deeley, and S. P. Cole, Characterization of vincristine transport by the M(r) 190,000 multidrug resistance protein (MRP): evidence for cotransport with reduced glutathione, Cancer Res, vol.58, pp.5130-5136, 1998.

L. Manciu, Intermediate structural states involved in MRP1-mediated drug transport. Role of glutathione, J. Biol. Chem, vol.278, pp.3347-3356, 2003.

C. F. Mueller, The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress, Circulation Res, vol.97, pp.637-644, 2005.

D. W. Loe, R. G. Deeley, and S. P. Cole, Verapamil stimulates glutathione transport by the 190-kDa multidrug resistance protein 1 (MRP1), J. Pharmacol. Exp. Ther, vol.293, pp.530-538, 2000.

A. Rothnie, R. Callaghan, R. G. Deeley, and S. P. Cole, Role of GSH in estrone sulfate binding and translocation by the multidrug resistance protein 1 (MRP1/ABCC1), J. Biol. Chem, vol.281, pp.13906-13914, 2006.

A. Rothnie, G. Conseil, A. Y. Lau, R. G. Deeley, and S. P. Cole, Mechanistic differences between GSH transport by multidrug resistance protein 1 (MRP1/ABCC1) and GSH modulation of MRP1-mediated transport, Mol. Pharmacol, vol.74, pp.1630-1640, 2008.

T. Perrotton, D. Trompier, X. B. Chang, and D. Pietro, A. & Baubichon-Cortay, H. R)-and (S)-verapamil differentially modulate the multidrug-resistant protein MRP1, J. Biol. Chem, vol.282, pp.31542-31548, 2007.
URL : https://hal.archives-ouvertes.fr/hal-01861697

D. Trompier, Verapamil and its derivative trigger apoptosis through glutathione extrusion by multidrug resistance protein MRP1, Cancer Res, vol.64, pp.4950-4956, 2004.
URL : https://hal.archives-ouvertes.fr/hal-00313600

W. Szybalski and V. Bryson, Genetic studies on microbial cross resistance to toxic agents. I. Cross resistance of Escherichia coli to fifteen antibiotics, J. Bacteriol, vol.64, pp.489-499, 1952.

G. Szakacs, Targeting the Achilles heel of multidrug-resistant cancer by exploiting the fitness cost of resistance, Chem. Rev, vol.114, pp.5753-5774, 2014.

D. Lorendeau, MRP1-dependent Collateral Sensitivity of Multidrug-resistant Cancer Cells: Identifying Selective Modulators Inducing Cellular Glutathione Depletion, Curr. Med. Chem, vol.24, pp.1186-1213, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02329651

R. Marchan, C. L. Hammond, and N. Ballatori, Multidrug resistance-associated protein 1 as a major mediator of basal and apoptotic glutathione release, Biochimica et. biophysica acta, vol.1778, pp.2413-2420, 2008.

J. Y. Cao, A Genome-wide Haploid Genetic Screen Identifies Regulators of Glutathione Abundance and Ferroptosis Sensitivity, Cell Rep, vol.26, pp.1544-1556, 2019.

L. Dury, Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1, Biochem. Pharmacol, vol.124, pp.10-18, 2017.
URL : https://hal.archives-ouvertes.fr/hal-02329628

P. E. Bandler, C. J. Westlake, C. E. Grant, S. P. Cole, and R. G. Deeley, Identification of Regions Required for Apical Membrane Localization of Human Multidrug Resistance Protein 2, Mol. Pharmacology, vol.74, pp.9-19, 2008.

C. E. Grant, M. Gao, M. K. Degorter, S. P. Cole, and R. G. Deeley, Structural determinants of substrate specificity differences between human multidrug resistance protein (MRP) 1 (ABCC1) and MRP3 (ABCC3), Drug. Metab. Dispos, vol.36, pp.2571-2581, 2008.

C. C. Paulusma, Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione, Biochem. J, vol.338, issue.2, pp.393-401, 1999.

S. P. Cole and R. G. Deeley, Transport of glutathione and glutathione conjugates by MRP1, Trends Pharmacol. Sci, vol.27, pp.438-446, 2006.

K. Ito, T. Horie, H. Suzuki, and Y. Sugiyama, Polarized expression of drug transporters and its physiological significance, Tanpakushitsu Kakusan Koso, vol.48, pp.122-132, 2003.

H. Lou, M. Ookhtens, A. Stolz, and N. Kaplowitz, Chelerythrine stimulates GSH transport by rat Mrp2 (Abcc2) expressed in canine kidney cells, Am. J. Physiol. Gastrointest. Liver Physiol, vol.285, pp.1335-1344, 2003.

A. M. Wielandt, Induction of the multispecific organic anion transporter (cMoat/mrp2) gene and biliary glutathione secretion by the herbicide 2,4,5-trichlorophenoxyacetic acid in the mouse liver, Biochem. J, vol.341, pp.105-111, 1999.

B. Yang and C. E. Hill, Nifedipine modulation of biliary GSH and GSSG/conjugate efflux in normal and regenerating rat liver, Am. J. Physiol. Gastrointest. Liver Physiol, vol.281, pp.85-94, 2001.

Y. Cui, Drug resistance and ATP-dependent conjugate transport mediated by the apical multidrug resistance protein, MRP2, permanently expressed in human and canine cells, Mol. Pharmacol, vol.55, pp.929-937, 1999.

E. Bakos, Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions, Mol. Pharmacol, vol.57, pp.760-768, 2000.

K. Koike, A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells, Cancer Res, vol.57, pp.5475-5479, 1997.

T. Kawabe, Enhanced transport of anticancer agents and leukotriene C4 by the human canalicular multispecific organic anion transporter (cMOAT/MRP2), FEBS Lett, vol.456, pp.327-331, 1999.

J. Karwatsky, R. Daoud, J. Cai, P. Gros, and E. Georges, Binding of a photoaffinity analogue of glutathione to MRP1 (ABCC1) within two cytoplasmic regions (L0 and L1) as well as transmembrane domains 10-11 and 16-17, Biochemistry, vol.42, pp.3286-3294, 2003.

J. M. Karwatsky and E. Georges, Drug binding domains of MRP1 (ABCC1) as revealed by photoaffinity labeling, Curr. Med. Chem. Anticancer. Agents, vol.4, pp.19-30, 2004.

P. Wu, Analysis of human multidrug resistance protein 1 (ABCC1) by matrix-assisted laser desorption ionization/time of flight mass spectrometry: toward identification of leukotriene C4 binding sites, Mol. Pharmacol, vol.68, pp.1455-1465, 2005.

G. Conseil, A. J. Rothnie, R. G. Deeley, and S. P. Cole, Multiple roles of charged amino acids in cytoplasmic loop 7 for expression and function of the multidrug and organic anion transporter MRP1 (ABCC1), Mol. Pharmacol, vol.75, pp.397-406, 2009.

S. H. Iram and S. P. Cole, Mutation of Glu521 or Glu535 in cytoplasmic loop 5 causes differential misfolding in multiple domains of multidrug and organic anion transporter MRP1 (ABCC1), J. Biol. Chem, vol.287, pp.7543-7555, 2012.

E. Baiceanu, 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2, Eur. J. Med. Chem, vol.122, pp.408-418, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01683292

S. H. Iram and S. P. Cole, Differential functional rescue of Lys(513) and Lys(516) processing mutants of MRP1 (ABCC1) by chemical chaperones reveals different domain-domain interactions of the transporter, Biochimica et. biophysica acta, vol.1838, pp.756-765, 2014.

G. Conseil, R. G. Deeley, and S. P. Cole, Functional importance of three basic residues clustered at the cytosolic interface of transmembrane helix 15 in the multidrug and organic anion transporter MRP1 (ABCC1), J. Biol. Chem, vol.281, pp.43-50, 2006.

V. Srinivasan, A. J. Pierik, and R. Lill, Crystal structures of nucleotide-free and glutathione-bound mitochondrial ABC transporter Atm1, Science, vol.343, pp.1137-1140, 2014.

Z. L. Johnson and J. Chen, Structural Basis of Substrate Recognition by the Multidrug Resistance Protein MRP1, Cell, vol.168, pp.1075-1085, 2017.

R. Laberge, J. Karwatsky, M. C. Lincoln, M. L. Leimanis, and E. Georges, Modulation of GSH levels in ABCC1 expressing tumor cells triggers apoptosis through oxidative stress, Biochemical Pharmacology, vol.73, pp.1727-1737, 2007.

G. Rappa, Retroviral transfer of MRP1 and gamma-glutamyl cysteine synthetase modulates cell sensitivity to L-buthionine-S,R-sulphoximine (BSO): new rationale for the use of BSO in cancer therapy, Eur. J. Cancer, vol.39, pp.120-128, 2003.

J. Y. Lee, J. G. Yang, D. Zhitnitsky, O. Lewinson, and D. C. Rees, Structural basis for heavy metal detoxification by an Atm1-type ABC exporter, Science, vol.343, pp.1133-1136, 2014.

Z. L. Johnson and J. Chen, ATP Binding Enables Substrate Release from Multidrug Resistance Protein 1, Cell, vol.172, pp.81-89, 2018.

J. Yang, P. Song, and G. Zhou, A study on the correlations of MRP-1 expression with the pathogenesis and prognosis of colorectal cancer, J. BUON, vol.24, pp.84-90, 2019.

S. H. Iram and S. P. Cole, Expression and function of human MRP1 (ABCC1) is dependent on amino acids in cytoplasmic loop 5 and its interface with nucleotide binding domain 2, J. Biol. Chem, vol.286, pp.7202-7213, 2011.

C. J. Westlake, Identification of the structural and functional boundaries of the multidrug resistance protein 1 cytoplasmic loop 3, Biochemistry, vol.42, pp.14099-14113, 2003.

Z. E. Sauna and C. Kimchi-sarfaty, Understanding the contribution of synonymous mutations to human disease, Nat. Rev. Genet, vol.12, pp.683-691, 2011.

K. Ito, S. L. Olsen, W. Qiu, R. G. Deeley, and S. P. Cole, Mutation of a single conserved tryptophan in multidrug resistance protein 1 (MRP1/ABCC1) results in loss of drug resistance and selective loss of organic anion transport, J. Biol. Chem, vol.276, pp.15616-15624, 2001.

G. Gyimesi, ABCMdb: a database for the comparative analysis of protein mutations in ABC transporters, and a potential framework for a general application, Hum. Mutat, vol.33, pp.1547-1556, 2012.

Y. M. Qian, Photolabeling of human and murine multidrug resistance protein 1 with the high affinity inhibitor [125I]LY475776 and azidophenacyl-[35S]glutathione, J. Biol. Chem, vol.277, pp.35225-35231, 2002.

M. M. Gottesman and I. Pastan, Biochemistry of multidrug resistance mediated by the multidrug transporter, Annu. Rev. Biochem, vol.62, pp.385-427, 1993.

Q. Mao, GSH-dependent photolabeling of multidrug resistance protein MRP1 (ABCC1) by [125I]LY475776. Evidence of a major binding site in the COOH-proximal membrane spanning domain, J. Biol. Chem, vol.277, pp.28690-28699, 2002.

I. L. Wong, Modulation of multidrug resistance protein 1 (MRP1/ABCC1)-mediated multidrug resistance by bivalent apigenin homodimers and their derivatives, J. Med. Chem, vol.52, pp.5311-5322, 2009.

Z. Zhang and J. Chen, Atomic Structure of the Cystic Fibrosis Transmembrane Conductance Regulator, Cell, vol.167, pp.1586-1597, 2016.

Z. Zhang, F. Liu, and J. Chen, Conformational Changes of CFTR upon Phosphorylation and ATP Binding, Cell, vol.170, pp.483-491, 2017.

Q. Mao, E. M. Leslie, R. G. Deeley, and S. P. Cole, ATPase activity of purified and reconstituted multidrug resistance protein MRP1 from drug-selected H69AR cells, Biochimica et. biophysica acta, vol.1461, pp.69-82, 1999.

K. E. Weigl, An Outward-Facing Aromatic Amino Acid Is Crucial for Signaling between the Membrane-Spanning and Nucleotide-Binding Domains of Multidrug Resistance Protein 1 (MRP1; ABCC1), Mol. Pharmacol, vol.94, pp.1069-1078, 2018.

E. Baiceanu, 2-Indolylmethylenebenzofuranones as first effective inhibitors of ABCC2, Eur J Med Chem, pp.408-418, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01683292

M. E. Anderson, Determination of glutathione and glutathione disulfide in biological samples, Methods Enzymol, vol.113, pp.548-555, 1985.

D. Lorendeau, Collateral sensitivity of resistant MRP1-overexpressing cells to flavonoids and derivatives through GSH efflux, Biochemical pharmacology, vol.90, pp.235-245, 2014.

K. F. Chan, Flavonoid dimers as bivalent modulators for P-glycoprotein-based multidrug resistance: synthetic apigenin homodimers linked with defined-length poly(ethylene glycol) spacers increase drug retention and enhance chemosensitivity in resistant cancer cells, J. medicinal Chem, vol.49, pp.6742-6759, 2006.

B. Webb and A. Sali, Comparative Protein Structure Modeling Using MODELLER, Curr. Protoc. Bioinforma, vol.54, 2016.

P. Emsley, B. Lohkamp, W. G. Scott, and K. Cowtan, Features and development of Coot, Acta Crystallogr. D. Biol. Crystallogr, vol.66, pp.486-501, 2010.

R. A. Nicholls, F. Long, and G. N. Murshudov, Low resolution refinement tools in REFMAC5, Acta Crystallogr. D. Biol. Crystallogr, vol.68, pp.404-417, 2012.